Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R24 DK082841, DK076169 Sub-award#25034, T32DK101357, P30 DK081943)
American Diabetes Association
University of Michigan Neuronetwork for Emerging Therapies
A. Alfred Taubman Medical Research Institute
National Institute of General Medical Sciences (P20 GM104360 Pilot Grant)
University of North Dakota
Nathan and Rose Milstein Research Fund
Received: 13 May 2020
Accepted: 27 July 2020
First Online: 12 August 2020
Change Date: 27 August 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: The use of human sural nerve samples was approved by the University of Michigan Institutional Review Board for Human Patient Research.
: Not applicable.
: The authors have nothing to disclose.